Abstract
The traditional view of follicle-stimulating hormone (FSH) as a reproductive hormone is changing. It has been shown that FSH receptors (FSHRs) are expressed in various extra-gonadal tissues and mediate the biological effects of FSH at those sites. Molecular, animal, epidemiologic, and clinical data suggest that elevated serum FSH may play a significant role in the evolution of bone loss and obesity, as well as contributing to cardiovascular and cancer risk. This review summarizes recent data on FSH action beyond reproduction.
Original language | English |
---|---|
Article number | 136 |
Journal | Frontiers in Endocrinology |
Volume | 10 |
Issue number | MAR |
DOIs | |
State | Published - 2019 |
Keywords
- BMI
- FSH
- FSHR
- cardiovascular risk
- obesity
- osteoporosis